Covered recipient · General Payments record
FREDERICK FISHER
Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine
General Payments · PY2018–2024
$3,728.92
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $914.06 | 3 |
| Food and Beverage | $270.05 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SI-BONE, INC. | $985.28 | 5 |
| Abbott Laboratories | $74.64 | 4 |
| Nevro Corp. | $47.95 | 2 |
| Averitas Pharma Inc. | $26.13 | 1 |
| Azurity Pharmaceuticals, Inc. | $18.99 | 1 |
| EAGLE PHARMACEUTICALS, INC. | $16.15 | 1 |
| Merck Sharp & Dohme Corporation | $14.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.63 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125297432 | CMS |
| Abbott Laboratories | $21.98 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125297434 | CMS |
| Abbott Laboratories | $14.32 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125297436 | CMS |
| Abbott Laboratories | $23.71 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125297438 | CMS |
| Averitas Pharma Inc. | $26.13 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426022 | CMS |
| Azurity Pharmaceuticals, Inc. | $18.99 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134005643 | CMS |
| EAGLE PHARMACEUTICALS, INC. | $16.15 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120208601 | CMS |
| Merck Sharp & Dohme LLC | $14.97 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141722500 | CMS |
| Nevro Corp. | $16.29 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760011 | CMS |
| Nevro Corp. | $31.66 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130760009 | CMS |
| SI-BONE, INC. | $720.21 | 05/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1120063364 | CMS |
| SI-BONE, INC. | $29.99 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120066533 | CMS |
| SI-BONE, INC. | $25.48 | 05/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1120066643 | CMS |
| SI-BONE, INC. | $168.37 | 05/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1120066689 | CMS |
| SI-BONE, INC. | $41.23 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120061580 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.